SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-24-000025
Filing Date
2024-04-05
Accepted
2024-04-05 16:33:57
Documents
19
Period of Report
2024-04-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K angn-20240405.htm   iXBRL 8-K 23012
2 EX-99.1 eliciotherapeutics_aacrr.htm EX-99.1 18973
6 eliciotherapeutics_aacrr001.jpg GRAPHIC 283670
7 eliciotherapeutics_aacrr002.jpg GRAPHIC 278592
8 eliciotherapeutics_aacrr003.jpg GRAPHIC 275400
9 eliciotherapeutics_aacrr004.jpg GRAPHIC 290751
10 eliciotherapeutics_aacrr005.jpg GRAPHIC 224172
  Complete submission text file 0001601485-24-000025.txt   2042264

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20240405.xsd EX-101.SCH 1989
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20240405_lab.xml EX-101.LAB 22786
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20240405_pre.xml EX-101.PRE 13130
22 EXTRACTED XBRL INSTANCE DOCUMENT angn-20240405_htm.xml XML 2816
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 24826991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)